Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. [electronic resource]
Producer: 20080513Description: 232-8 p. digitalISSN:- 0304-3835
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Aromatase Inhibitors
- Benzamides
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Chemotherapy, Adjuvant
- Drug Evaluation
- Female
- Humans
- Imatinib Mesylate
- Letrozole
- Middle Aged
- Neoadjuvant Therapy
- Neoplasms, Hormone-Dependent -- drug therapy
- Nitriles -- therapeutic use
- Pilot Projects
- Piperazines -- therapeutic use
- Postmenopause
- Pyrimidines -- therapeutic use
- Signal Transduction
- Triazoles -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.